Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2005 Jun 1;61(Pt 6):591–594. doi: 10.1107/S1744309105015642

Expression, purification, crystallization and preliminary X-ray analysis of a nucleoside kinase from the hyperthermophile Methanocaldococcus jannaschii

Linda Arnfors a, Thomas Hansen b, Winfried Meining a, Peter Schönheit b, Rudolf Ladenstein a,*
PMCID: PMC1952333  PMID: 16511104

Nucleoside kinase from the hyperthermophilic archaeon M. jannaschii is a member of the PFK-B family which belongs to the ribokinase superfamily. Here, its expression, purification, crystallization and preliminary X-ray analysis are described.

Keywords: Methanocaldococcus jannaschii, phosphofructokinase B family, ribokinase superfamily, nucleoside kinases, hyperthermophiles, archaea

Abstract

Methanocaldococcus jannaschii nucleoside kinase (MjNK) is an ATP-dependent non-allosteric phosphotransferase that shows high catalytic activity for guanosine, inosine and cytidine. MjNK is a member of the phosphofructokinase B family, but participates in the biosynthesis of nucleoside monophosphates rather than in glycolysis. MjNK was crystallized as the apoenzyme as well as in complex with an ATP analogue and Mg2+. The latter crystal form was also soaked with fructose-6-phosphate. Synchrotron-radiation data were collected to 1.70 Å for the apoenzyme crystals and 1.93 Å for the complex crystals. All crystals exhibit orthorhombic symmetry; however, the apoenzyme crystals contain one monomer per asymmetric unit whereas the complex crystals contain a dimer.

1. Introduction

The phosphofructokinase B family (PFK-B family; Prosite PS00583 and PS00584; Pfam PF00294) is a diverse protein family within the ribokinase superfamily (SCOP 53613) present in all three domains of life: archaea, bacteria and eukarya. The PFK-B protein family includes a variety of non-allosteric ATP-dependent kinases, e.g. inosine-guanosine kinases, tagatose-6-phosphate kinases, ribokinases, fructokinases and 1-phosphofructokinases, as well as the minor 6-­phosphofructokinase (PFK-B) from Escherichia coli and the 6-­phosphofructokinases from the archaea Desulfurococcus amylolyticus and Aeropyrum pernix (Bork et al., 1993; Hansen & Schönheit, 2000, 2001). The latter PFKs are not related to the ATP-dependent 6-­phosphofructokinases from the phosphofructokinase A family (Pfam PF00365; Wu et al., 1991; Ronimus & Morgan, 2001), which represent key regulatory enzymes in the Embden–Meyerhof pathways of various bacteria and eukarya (Wu et al., 1991; Ronimus & Morgan, 2001; Hansen et al., 2002). Moreover, ADP-dependent 6-­phosphofructokinases and glucokinases constitute a separate protein family within the ribokinase superfamily (Pfam PF04587; Ito et al., 2001).

Seven structures of enzymes from the PFK-B family have been described so far. These include E. coli ribokinase (PDB code http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1rkd), human and Toxoplasma gondii adenosine kinases (http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1bx4 and http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1dgm), the 2-keto-3-deoxygluconate kinases from Thermotoga maritima (http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1j5v) and Thermus thermophilus (http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1v1s), sheep pyridoxal kinase (http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1lhp) and putative 1-phosphofructokinase from Thermotoga maritima (http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1o14) (Sigrell et al., 1998; Mathews et al., 1998; Schumacher et al., 2000; Ohshima et al., 2004; Li et al., 2002; Joint Center For Structural Genomics, unpublished results). A structure of an archaeal member of the PFK-B family has not yet been reported. The structures of the ADP-dependent glucokinases from Thermococcus litoralis (PDB code http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1gc5) and Pyrococcus furiosus (http://www.rcsb.org/pdb/cgi/explore.cgi?pdbId=1ua4) were the first archaeal representatives within the ribokinase superfamily (Ito et al., 2001). For a better understanding of the evolution of the ribo­kinase superfamily as well as of sugar kinases in general, additional structures of members of the PFK-B family are necessary.

In 1996, when the complete genome of Methanocaldococcus jannaschii was released, Bult and coworkers described the gene product of MJ0406 as a hypothetical PFK-B sugar kinase (Bult et al., 1996). Owing to sequence similarity to the A. pernix PFK-B 6-­phosphofructokinase (Hansen & Schönheit, 2001), it has been suggested that MJ0406 might also encode a PFK-B. However, characterization of the respective heterologous protein revealed that MJ0406 catalyzes the ATP-dependent phosphorylation of several substrates. The enzyme, which was designed as a nucleoside kinase (MjNK), showed the highest catalytic activity with guanosine, inosine and cytidine, but used fructose-6-phosphate only to a very low extent (Hansen & Schönheit, unpublished work). Thus, MjNK plays a role in the nucleoside metabolism rather than in sugar degradation in M. jannaschii.

Moreover, the three-dimensional structure of MjNK will help in understanding the wide substrate range of the enzyme as well as the evolution and non-allosteric nature of the PFK-B family and will provide additional data on the structural factors that give rise to thermostability of proteins.

Here, we describe the expression, purification, crystallization and preliminary X-ray analysis of M. jannaschii nucleoside kinase.

2. Materials and methods

2.1. Expression

E. coli BL 21 (DE3) pLys S cells were transformed with a pET-17b plasmid which contained the mjnk gene (Hansen & Schönheit, unpublished work). Transformed cells were grown in 400 ml Luria–Bertani medium with 100 µg ml−1 carbenicillin and 34 µg ml−1 chloramphenicol at 310 K. When the cells reached an optical density at 600 nm of 0.8, protein expression was induced by the addition of 0.8 mM IPTG. After further 4 h of growth (OD600 ≃ 3.2–3.6), the cells were harvested by centrifugation at 277 K and then washed in a buffer containing 50 mM Tris–HCl pH 7.0 and 50 mM NaCl.

2.2. Purification

All chromatographic steps were carried out at 277 K. Cell extracts were prepared by French press treatment (1.3 × 108 Pa) of cell suspensions in buffer A (50 mM Tris–HCl pH 8.4). After ultracentrifugation (100 000g for 60 min), the solution was heat-precipitated at 353 K for 45 min, centrifuged again (15 000g for 30 min), dialyzed three times against a 30-fold excess of 50 mM Tris–HCl pH 8.0 (buffer B) and applied onto a DEAE Sepharose column (60 ml) previously equilibrated with buffer B. The protein was eluted at a flow rate of 3 ml min−1 with 180 ml 50 mM piperazine pH 6.5 at 298 K (buffer C) as well with a combination of fixed NaCl concentration and linear gradients from 0 to 2 M NaCl in buffer B: 0–0.1 M (120 ml), 0.1–1 M (180 ml), 1–2 M (120 ml) and 2 M NaCl (120 ml). Fractions containing the highest nucleoside kinase activity (160 ml, 0.2–1 M NaCl) were pooled and diluted with 3 M ammonium sulfate in buffer B to a final ammonium sulfate concentration of 2 M. Subsequently, the solution was applied onto a phenyl-Sepharose column (15 ml) previously equilibrated with 2 M ammonium sulfate in buffer B. The protein was eluted with a linear ammonium sulfate gradient (2–0 M, 150 ml) followed by washing the column with 60 ml 50 mM Tris–HCl pH 8.0 and 60 ml water. Fractions containing nucleoside kinase activity (75 ml, 1.2–0.2 M ammonium sulfate) were checked for purity with respect to protein and DNA impurities. MjNK, which was almost pure (45 ml, 0.8–0.2 M ammonium sulfate, protein and DNA contamination <5%), was used for further purification. The protein was concentrated by ultrafiltration (exclusion size 10 kDa) and then applied onto a Superdex 200 gel-filtration column (120 ml) previously equilibrated with buffer D (150 mM NaCl, 50 mM Tris–HCl pH 7.5); pure MjNK was obtained (72–86 ml) from this step.

2.3. Crystallization

M. jannaschii nucleoside kinase was dialyzed against 20 mM Tris–HCl pH 8.0 containing 0.02% sodium azide, concentrated to a protein concentration of 13 mg ml−1 and kept at 277 K. For crystallization of the complex, MjNK was mixed with the ATP analogue AMPPNP and MgCl2 in the ratio 1:10:20 and incubated for at least 15 h. In order to find crystallization conditions for both the apo form (MjNK-apo) and the complex with AMPPNP (MjNK-A), homemade screening sets identical to commercially available screens [Crystal Screen I (Jancarik & Kim, 1991), Crystal Screen Lite (Jancarik & Kim, 1991; McPherson, 1990), Natrix (Scott et al., 1995) and PEG/Ion Screen from Hampton Research] were used. Promising conditions were optimized using a finer grid search. All crystallization experiments were carried out at 293 K using the sitting-drop or hanging-drop vapour-diffusion methods; the latter method was preferred in order to prevent crystals from sticking to the plate. 2.5 µl mother liquor was added to a fresh drop of an equal volume of protein solution and the drops were allowed to equilibrate against 500 µl mother liquor. A total concentration of 0.02% azide was used in all crystallization drops. Some of the complex crystals were further soaked with 10 mM fructose-6-phosphate in mother liquor for at least 24 h. The soaked crystals are referred to as MjNK-AF. Suitable cryoconditions were screened by the addition of polyethylene glycol 400, glycerol and ethylene glycol. The cryoprotectant solutions for each crystal form contained the mother-liquor composition with the addition of 30% ethylene glycol for MjNK-apo and 20% ethylene glycol for MjNK-A and MjNK-AF.

2.4. Data collection and preliminary X-ray analysis

Prior to data collection, the crystals were soaked for 1 min in the cryoprotectant solution and flash-cooled in liquid nitrogen. Synchrotron-radiation data for MjNK-apo were collected on beamline I711 at MAX-lab (Lund, Sweden) at a wavelength of 1.134 Å using a MAR Research imaging-plate detector. Data for the two complex forms were collected at beamline X11 at the EMBL Outstation, DESY (Hamburg, Germany) at a wavelength of 0.8098 Å using a MAR CCD detector. For all three crystal forms, both high- and low-resolution data sets were collected. The data were indexed and scaled using the HKL package programs DENZO and SCALEPACK (Otwinowski & Minor, 1997).

3. Results and discussion

M. jannaschii nucleoside kinase has been crystallized in two forms: an apo form (MjNK-apo) and a form with the protein in complex with AMPPNP and MgCl2 (MjNK-A). Some of the MjNK-A crystals were further soaked with fructose-6-phosphate (MjNK-AF).

MjNK-apo crystals were obtained from a solution containing 10%(w/v) PEG 3500 and 0.15 M magnesium acetate. MjNK-A crystallized from a solution containing 15% PEG 4000, 0.10 M MgCl2 and 0.1 M Tris–HCl pH 8.5. Colourless orthorhombic crystals (Fig. 1) appeared within 1–4 d.

Figure 1.

Figure 1

Orthorhombic crystals of M. jannaschii nucleoside kinase showing (a) the apo form (MjNK-apo) and (b) the enzyme in complex with the ATP analogue AMPPNP and MgCl2. The crystal sizes for MjNK-apo and MjNK-A were 0.1 × 0.3 × 0.3 and 0.2 × 0.2 × 0.2 mm, respectively.

Data-collection parameters and statistics of the three crystal forms of M. jannaschii nucleoside kinase are summarized in Table 1. Pseudo-precession photographs (Lu, 1999) of the diffraction data evaluated in space group P222 showed systematic extinctions at h = 2n + 1, k = 2n + 1, l = 2n for MjNK-apo and h = 2n + 1, k = 2n + 1, l = 2n + 1 for MjNK-A and MjNK-AF. The space groups were thus assigned as P21212 for MjNK-apo and P212121 for the two complex forms. Moreover, the unit-cell parameters of the apo form and the complexes are almost identical with one exception. The b axes of the complexes (b = 83.2 Å for MjNK-A and b = 83.1 Å for MjNK-AF) are twice as long as the c axis for MjNK-apo (c = 41.1 Å). This results in a unit-cell volume twice the size for the complex crystals and thus the unit cell of MjNK-apo contains half the number of subunits compared with MjNK-A and MjNK-AF. In addition, the calculated Matthews coefficient (V M; Matthews, 1968) of 2.88 Å3 Da−1 for four monomers in the unit cell of MjNK-apo indicated that the crystal contains one subunit per asymmetric unit. This corresponds to a solvent content of 56.9%. Gel-filtration data reveals that MjNK exists as a dimer in solution (Hansen & Schönheit, unpublished results). Therefore, it is concluded that the biological dimer is generated by a twofold crystallographic symmetry operation in the apo crystals. Owing to the different unit-cell volumes and according to the calculated Matthews coefficients (Table 1), MjNK-A and MjNK-AF contain one dimer per asymmetric unit, with solvent contents of 57.2 and 56.9%, respectively. The self-rotation function obtained from the MjNK-A and MjNK-AF data, calculated with the programs MOLREP (Vagin & Teplyakov, 1997), AMoRe (Navaza, 1994) and POLARRFN (Collaborative Computational Project, Number 4, 1994) in the CCP4 suite, shows no additional twofold symmetry apart from crystallographic symmetry (Fig. 2). Furthermore, the native Patterson map calculated with FFT (Read & Schierbeek, 1988) within the CCP4 suite of programs reveals a pseudo-origin peak at (uvw) = (0.0, 0.5, 0.0) (Fig. 3) with an intensity of 25% of the Patterson origin peak. The results from the self-rotation function and the native Patterson indicate that the twofold non-crystallographic symmetry axis relating the two subunits in the asymmetric unit is parallel to the y axis in the unit cell.

Table 1. Crystallographic data analysis.

Values in parentheses are for the highest resolution shell.

  MjNK-apo MjNK-A MjNK-AF
Space group P21212 P212121 P212121
Unit-cell parameters (Å, °) a = 64.1, b = 148.1, c = 41.1, α = β = γ = 90 a = 64.2, b = 83.2, c = 147.0, α = β = γ = 90 a = 64.0, b = 83.1, c = 146.8, α = β = γ = 90
Resolution (Å) 50–1.70 (1.73–1.70) 20–1.93 (1.96–1.93) 20–1.93 (1.96–1.93)
No. of observations 694623 1132735 800362
Unique reflections 44110 58677 58526
Completeness (%) 100 (100) 97.4 (83.5) 97.0 (85.8)
I〉/〈σ(I)〉 41.5 (3.3) 19.3 (1.2) 19.9 (1.4)
Rmerge (%) 4.3 (65.4) 5.9 (55.7) 6.0 (65.7)
Subunits per AU 1 2 2
VM3 Da−1) 2.88 2.90 2.88

R merge = Inline graphic Inline graphic.

Figure 2.

Figure 2

Stereographic plot of the self-rotation function at the section κ = 180° calculated from the MjNK-AF data. The integration radius is between 15 and 5 Å and the resolution limits are 10–4 Å. Contour lines are drawn in steps of 10%. Only high peaks arising from crystallographic symmetry can be seen, which indicates that the twofold non-crystallographic axis is parallel to a crystallographic axis. The plot was produced using POLARRFN (Collaborative Computational Project, Number 4, 1994).

Figure 3.

Figure 3

Native Patterson function calculated from all data from the MjNK-AF complex. The plot shows fractional coordinates of u and w ranging from 0.0 to 0.5 at Harker section v = 0.5. An intense pseudo-origin peak appears at (u, w) = (0.0, 0.0). Grid lines are drawn every 0.10 units and contours are drawn every 0.5% of the origin peak hight, starting at 1.5%. The figure was prepared with the programs NPO and PLTDEV from the CCP4 suite (Collaborative Computational Project, Number 4, 1994).

Acknowledgments

We gratefully acknowledge MAX-lab (Lund, Sweden) and the EMBL Outstation at DESY (Hamburg, Germany) for provision of synchrotron-radiation facilities. We thank the European Community Research Infrastructure Action under the FP6 ‘Structuring the European Research Area Programme’ contract No. HPRI/1999/CT/00017 for travel expenses and NorFA (Norway) for financial support under the ‘Biology of Thermophiles’ project.

References

  1. Bork, P., Sander, C. & Valencia, A. (1993). Protein Sci.2, 31–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bult, C. J. et al. (1996). Science, 273, 1058–1073. [DOI] [PubMed] [Google Scholar]
  3. Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50, 760–763. [Google Scholar]
  4. Hansen, T., Musfeldt, M. & Schönheit, P. (2002). Arch. Microbiol.177, 401–409. [DOI] [PubMed] [Google Scholar]
  5. Hansen, T. & Schönheit, P. (2000). Arch. Microbiol.173, 103–109. [DOI] [PubMed] [Google Scholar]
  6. Hansen, T. & Schönheit, P. (2001). Arch. Microbiol.177, 62–69. [DOI] [PubMed] [Google Scholar]
  7. Ito, S., Fushinobu, S., Yoshioka, I., Koga, S., Matsuzawa, H. & Wakagi, T. (2001). Structure, 9, 205–214. [DOI] [PubMed] [Google Scholar]
  8. Jancarik, J. & Kim, S.-H. (1991). J. Appl. Cryst.24, 409–411. [Google Scholar]
  9. Li, M. H., Kwok, F., Chang, W. R., Lau, C. K., Zhang, J. P., Lo, S. C., Jiang, T. & Liang, D. C. (2002). J. Biol. Chem.277, 46385–46390. [DOI] [PubMed] [Google Scholar]
  10. Lu, G. (1999). J. Appl. Cryst.32, 375–376. [Google Scholar]
  11. McPherson, A. (1990). Eur. J. Biochem.189, 1–23. [DOI] [PubMed] [Google Scholar]
  12. Mathews, I. I., Erion, M. D. & Ealick, S. E. (1998). Biochemistry, 37, 15607–15620. [DOI] [PubMed] [Google Scholar]
  13. Matthews, B. W. (1968). J. Mol. Biol.33, 491–497. [DOI] [PubMed] [Google Scholar]
  14. Navaza, J. (1994). Acta Cryst. A50, 157–163. [Google Scholar]
  15. Ohshima, N., Inagaki, E., Yasuike, K., Takio, K. & Tahirov, T. (2004). J. Mol. Biol.340, 477–489. [DOI] [PubMed] [Google Scholar]
  16. Otwinowski, Z. & Minor, W. (1997). Methods Enzymol.276, 307–326. [DOI] [PubMed]
  17. Read, R. J. & Schierbeek, A. J. (1988). J. Appl. Cryst.21, 490–495. [Google Scholar]
  18. Ronimus, R. S. & Morgan, H. W. (2001). Extremophiles, 5, 357–373. [DOI] [PubMed] [Google Scholar]
  19. Schumacher, M. A., Scott, D. M., Mathews, I. I., Ealick, S. E., Roos, D. S., Ullman, B. & Brennan, R. G. (2000). J. Mol. Biol.298, 875–893. [DOI] [PubMed] [Google Scholar]
  20. Scott, W. G., Finch, J. T., Grenfell, R., Fogg, J., Smith, T., Gait, M. J. & Klug, A. (1995). J. Mol. Biol.250, 327–332. [DOI] [PubMed] [Google Scholar]
  21. Sigrell, J. A., Cameron, A. D., Jones, T. A. & Mowbray, S. L. (1998). Structure, 6, 183–193. [DOI] [PubMed] [Google Scholar]
  22. Vagin, A. & Teplyakov, A. (1997). J. Appl. Cryst.30, 1022–1025. [Google Scholar]
  23. Wu, L.-F., Reizer, A., Reizer, J., Cai, B., Tomich, J. M. & Saier, M. H. Jr (1991). J. Bacteriol.173, 3117–3127. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES